Infection with hepatitis GB virus C in patients on maintenance hemodialysis.

BACKGROUND A recently discovered non-A-E hepatitis virus has been designated hepatitis GB virus C (HGBV-C), but little is known about its mode of transmission and its clinical manifestations. We studied 519 patients on maintenance hemodialysis to determine whether they were infected with HGBV-C. METHODS HGBV-C RNA was identified in serum by a reverse-transcription-polymerase-chain-reaction assay with nested primers deduced from a non-structural region. A nucleotide sequence of 100 bp in the nonstructural region was determined on HGBV-C clones. RESULTS HGBV-C RNA was detected on 3.1 percent of the patients on hemodialysis (16 of 519), as compared with 0.9 percent of healthy blood donors (4 of 448, P<0.03). None of the 16 patients had evidence of active liver disease, although 7 were also infected with hepatitis C virus. Eight patients with HGBV-C infection were followed for 7 to 16 years. In two patients the virus was present at the start of hemodialysis. One had a history of transfusion, and HGBV-C persisted over a period of 16 years; the other became free of HGBV-C after 10 years. In five patients, HGBV-C RNA was first detected 3 to 20 weeks after blood transfusion and persisted for up to 13 years. One patient with no history of transfusion was infected with an HGBV-C variant with the same sequence as in two of the patients with post-transfusion HGBV-C infections. CONCLUSIONS Patients on maintenance hemodialysis are at increased risk for HGBV-C infection. This virus produces persistent infections, which may be transmitted by transfusions but may also be transmitted by other means.

[1]  H. Margolis,et al.  Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent , 1996, Science.

[2]  H. Okamoto,et al.  Hepatitis G infection in drug abusers with chronic hepatitis C. , 1996, The New England journal of medicine.

[3]  S. Mishiro,et al.  Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology , 1995, The Lancet.

[4]  T. Pilot‐Matias,et al.  Isolation of novel virus-like sequences associated with human hepatitis , 1995, Nature Medicine.

[5]  T. Pilot‐Matias,et al.  Molecular and serologic analysis in the transmission of the GB hepatitis agents , 1995, Journal of medical virology.

[6]  T. Pilot‐Matias,et al.  Identification of two flavivirus-like genomes in the GB hepatitis agent. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Okamoto,et al.  Hepatitis B Virus Strains with Mutations in the Core Promoter in Patients with Fulminant Hepatitis , 1995, Annals of Internal Medicine.

[8]  D. Bradley,et al.  Non-A, Non-B Hepatitis Unrelated to the Hepatitis C Virus (Non-ABC) , 1995, Seminars in liver disease.

[9]  S. Mishiro,et al.  Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a , 1994, Hepatology.

[10]  K. Masuko,et al.  Hepatitis C virus antibodies, viral RNA and genotypes in sera from patients on maintenance haemodialysis , 1994, Journal of viral hepatitis.

[11]  T. Chan,et al.  Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays , 1993, Hepatology.

[12]  Y. Ito,et al.  Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. , 1992, Virology.

[13]  H. Okamoto,et al.  Correlation between Anti‐HBc Titers and HBV DNA in Blood Units without Detectable HBsAg , 1992, Vox sanguinis.

[14]  A. Muñoz,et al.  The declining risk of post-transfusion hepatitis C virus infection. , 1992, The New England journal of medicine.

[15]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[16]  J. Wands,et al.  A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. , 1991, The New England journal of medicine.

[17]  R. Purcell,et al.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Takase,et al.  Fulminant hepatitis B: induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e antigen. , 1991, Gastroenterology.

[19]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[20]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[21]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[22]  W. P. Reed,et al.  Host defenses and immunologic alterations associated with chronic hemodialysis. , 1980, Annals of internal medicine.

[23]  A. Sutnick,et al.  An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. , 1969, The New England journal of medicine.

[24]  F. Deinhardt,et al.  STUDIES ON THE TRANSMISSION OF HUMAN VIRAL HEPATITIS TO MARMOSET MONKEYS , 1967, The Journal of experimental medicine.